Successful Desensitization Protocol for Hypersensitivity Reaction Caused by Irinotecan in a Patient With Metastatic Colorectal Cancer

Clin Colorectal Cancer. 2015 Dec;14(4):e49-51. doi: 10.1016/j.clcc.2015.05.003. Epub 2015 May 22.

¹ Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
² Department of Immunology, Rambam Health Care Campus and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
³ Pharmacy Department, Rambam Health Care Campus and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
⁴ Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Electronic address: g_barsela@rambam.health.gov.il.

No abstract available

Keywords: Chemotherapy agents; Desensitization; Hypersensitivity reactions; Irinotecan.

Publication types